Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

Science Translational Medicine

Volumn 11, Issue 494, 2019, Pages

  Lo, Michael K ^a   Feldmann, Friederike ^b   Gary, Joy M ^a   Jordan, R ^c,d   Bannister, Roy ^c   Cronin, Jacqueline ^b   Patel, Nishi R ^a   Klena, John D ^a   Nichol, Stuart T ^a   Cihlar, Tomas ^c   Zaki, Sherif R ^a   Feldmann, Heinz ^b   Spiropoulou, Christina F ^a   De Wit, Emmie ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GILEAD SCIENCES   (United States)

^d VIR Biotechnology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REMDESIVIR; ADENOSINE PHOSPHATE; ALANINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLOROCEBUS AETHIOPS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENOTYPE; HISTOLOGY; MALE; MENINGOENCEPHALITIS; NIPAH VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BLOOD; BRAIN; HENIPAVIRUS INFECTION; NIPAH VIRUS; PATHOLOGY; SERODIAGNOSIS; VIREMIA; VIROLOGY;

ADENOSINE MONOPHOSPHATE; ALANINE; ANIMALS; BRAIN; CHLOROCEBUS AETHIOPS; FEMALE; HENIPAVIRUS INFECTIONS; MALE; MENINGOENCEPHALITIS; NEUTRALIZATION TESTS; NIPAH VIRUS; VIREMIA; VIRUS REPLICATION;

EID: 85066838285     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aau9242     Document Type: Article

References (24)

1. B. S. P. Ang, T. C. C. Lim, L. Wang, Nipah virus infection. J. Clin. Microbiol. 56, e01875-17 (2018).
2. G. Arunkumar, R. Chandni, D. T. Mourya, S. K. Singh, R. Sadanandan, P. Sudan, B. Bhargava, Nipah Investigators People and Health Study Group, Outbreak investigation of Nipah virus disease in Kerala, India, 2018. J. Infect. Dis. 2018, jiy612 (2018).
3. World Health Organization, WHO publishes list of top emerging disease likely to cause major epidemics (2015); www.who.int/medicines/ebola-treatment/WHO-list-of-top-emergingdiseases/ en/.
4. B. E. Dawes, B. Kalveram, T. Ikegami, T. Juelich, J. K. Smith, L. Zhang, A. Park, B. Lee, T. Komeno, Y. Furuta, A. N. Freiberg, Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci. Rep. 8, 7604 (2018).
5. C. Mathieu, M. Porotto, T. N. Figueira, B. Horvat, A. Moscona, Fusion inhibitory lipopeptides engineered for prophylaxis of Nipah virus in primates. J. Infect. Dis. 218, 218-227 (2018).
6. T. W. Geisbert, C. E. Mire, J. B. Geisbert, Y.-P. Chan, K. N. Agans, F. Feldmann, K. A. Fenton, Z. Zhu, D. S. Dimitrov, D. P. Scott, K. N. Bossart, H. Feldmann, C. C. Broder, Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci. Transl. Med. 6, 242ra82 (2014).
7. C. E. Mire, B. A. Satterfield, J. B. Geisbert, K. N. Agans, V. Borisevich, L. Yan, Y.-P. Chan, R. W. Cross, K. A. Fenton, C. C. Broder, T. W. Geisbert, Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: Implications for antibody therapy. Sci. Rep. 6, 30916 (2016).
8. M. K. Lo, R. Jordan, A. Arvey, J. Sudhamsu, P. Shrivastava-Ranjan, A. L. Hotard, M. Flint, L. K. McMullan, D. Siegel, M. O. Clarke, R. L. Mackman, H. C. Hui, M. Perron, A. S. Ray, T. Cihlar, S. T. Nichol, C. F. Spiropoulou, GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses. Sci. Rep. 7, 43395 (2017).
9. T. P. Sheahan, A. C. Sims, R. L. Graham, V. D. Menachery, L. E. Gralinski, J. B. Case, S. R. Leist, K. Pyrc, J. Y. Feng, I. Trantcheva, R. Bannister, Y. Park, D. Babusis, M. O. Clarke, R. L. Mackman, J. E. Spahn, C. A. Palmiotti, D. Siegel, A. S. Ray, T. Cihlar, R. Jordan, M. R. Denison, R. S. Baric, Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med. 9, eaal3653 (2017).
10. National Institutes of Health, Clinical trial of investigational Ebola treatments begins in the Democratic Republic of the Congo (2018); www.nih.gov/news-events/news-releases/ clinical-trial-investigational-ebola-treatments-begins-democratic-republic-congo.
11. S. Abdullah, L.-Y. Chang, K. Rahmat, K. J. Goh, C. T. Tan, Late-onset Nipah virus encephalitis 11 years after the initial outbreak: A case report. Neurol. Asia 17, 71-74 (2012).
12. J. J. Sejvar, J. Hossain, S. K. Saha, E. S. Gurley, S. Banu, J. D. Hamadani, M. A. Faiz, F. M. Siddiqui, Q. D. Mohammad, A. H. Mollah, R. Uddin, R. Alam, R. Rahman, C. T. Tan, W. Bellini, P. Rota, R. F. Breiman, S. P. Luby, Long-term neurological and functional outcome in Nipah virus infection. Ann. Neurol. 62, 235-242 (2007).
13. C. T. Tan, K. J. Goh, K. T. Wong, S. A. Sarji, K. B. Chua, N. K. Chew, P. Murugasu, Y. L. Loh, H. T. Chong, K. S. Tan, T. Thayaparan, S. Kumar, M. R. Jusoh, Relapsed and late-onset Nipah encephalitis. Ann. Neurol. 51, 703-708 (2002).
14. S. C. Wong, M. H. Ooi, M. N. L. Wong, P. H. Tio, T. Solomon, M. J. Cardosa, Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response. J. Neurol. Neurosurg. Psychiatry 71, 552-554 (2001).
15. T. K. Warren, R. Jordan, M. K. Lo, A. S. Ray, R. L. Mackman, V. Soloveva, D. Siegel, M. Perron, R. Bannister, H. C. Hui, N. Larson, R. Strickley, J. Wells, K. S. Stuthman, S. A. Van Tongeren, N. L. Garza, G. Donnelly, A. C. Shurtleff, C. J. Retterer, D. Gharaibeh, R. Zamani, T. Kenny, B. P. Eaton, E. Grimes, L. S. Welch, L. Gomba, C. L. Wilhelmsen, D. K. Nichols, J. E. Nuss, E. R. Nagle, J. R. Kugelman, G. Palacios, E. Doerffler, S. Neville, E. Carra, M. O. Clarke, L. Zhang, W. Lew, B. Ross, Q. Wang, K. Chun, L. Wolfe, D. Babusis, Y. Park, K. M. Stray, I. Trancheva, J. Y. Feng, O. Barauskas, Y. Xu, P. Wong, M. R. Braun, M. Flint, L. K. McMullan, S.-S. Chen, R. Fearns, S. Swaminathan, D. L. Mayers, C. F. Spiropoulou, W. A. Lee, S. T. Nichol, T. Cihlar, S. Bavari, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381-385 (2016).
16. M. Jacobs, A. Rodger, D. J. Bell, S. Bhagani, I. Cropley, A. Filipe, R. J. Gifford, S. Hopkins, J. Hughes, F. Jabeen, I. Johannessen, D. Karageorgopoulos, A. Lackenby, R. Lester, R. S. N. Liu, A. MacConnachie, T. Mahungu, D. Martin, N. Marshall, S. Mepham, R. Orton, M. Palmarini, M. Patel, C. Perry, S. E. Peters, D. Porter, D. Ritchie, N. D. Ritchie, R. A. Seaton, V. B. Sreenu, K. Templeton, S. Warren, G. S. Wilkie, M. Zambon, R. Gopal, E. C. Thomson, Late Ebola virus relapse causing meningoencephalitis: A case report. Lancet 388, 498-503 (2016).
17. National Institutes of Health, PREVAIL treatment trial for men with persistent Ebola virus RNA in semen opens in Liberia (2016); www.nih.gov/news-events/news-releases/ prevail-treatment-trial-men-persistent-ebola-viral-rna-semen-opens-liberia.
18. A. Chakraborty, H. M. Sazzad, M. J. Hossain, M. S. Islam, S. Parveen, M. Husain, S. S. Banu, G. Podder, S. Afroj, P. E. Rollin, P. Daszak, S. P. Luby, M. Rahman, E. S. Gurley, Evolving epidemiology of Nipah virus infection in Bangladesh: Evidence from outbreaks during 2010-2011. Epidemiol. Infect. 144, 371-380 (2016).
19. J. Dörnemann, C. Burzio, A. Ronsse, A. Sprecher, H. De Clerck, M. Van Herp, M.-C. Kolié, V. Yosifiva, S. Caluwaerts, A. K. McElroy, A. Antierens, First newborn baby to receive experimental therapies survives Ebola virus disease. J. Infect. Dis. 215, 171-174 (2017).
20. Clinical Trials.gov, GS-5734 to assess the antiviral activity, longer-term clearance of Ebola virus and safety in male Ebola survivors with evidence of Ebola virus persistence in semen (2016); http://clinicaltrials.gov/ct2/show/NCT02818582?term=GS-5734&rank=1.
21. Clinical Trials.gov, Investigational therapeutics for the treatment of people with Ebola virus disease (2018); http://clinicaltrials.gov/ct2/show/NCT03719586?term=remdesivir&rank=1.
22. E. Haddock, F. Feldmann, H. Feldmann, Effective chemical inactivation of Ebola virus. Emerg. Infect. Dis. 22, 1292-1294 (2016).
23. K. T. Wong, W.-J. Shieh, S. Kumar, K. Norain, W. Abdullah, J. Guarner, C. S. Goldsmith, K. B. Chua, S. K. Lam, C. T. Tan, K. J. Goh, H. T. Chong, R. Jusoh, P. E. Rollin, T. G. Ksiazek, S. R. Zaki, Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am. J. Pathol. 161, 2153-2167 (2002).
24. P. Daniels, T. Ksiazek, B. T. Eaton, Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect. 3, 289-295 (2001).